Good Morning Rappers!
I awoke this morning feeling excited.. For the soon to be expected CE mark approval of course!
Alas, no CE today but are we next in line?
On the 31 of May 2019 SugarBeat by Nemaura received their CE approval for a worlds first wearable noninvasive continuous glucose monitor which is tracked on the users smart-device. It's an interesting read:
https://www.medtechdive.com/news/wearable-glucose-monitor-wins-ce-mark-as-market-gets-crowded/555920/That was only 4 days ago! Now here's the EXCITING part!
Nemaura CE review process was based on a Fast Track application and Announced Completion of Key Stages of Technical File Review for SugarBEAT CE Mark Approval on 21st of December 2018. Another interesting read:
https://nemauramedical.com/nemaura-announces-completion-of-key-stages-of-technical-file-review-for-sugarbeat-ce-mark-approval/Upon CE mark announcement Nemaura sock (NASDAQ: NMRD) rose 30%!
What is my take from all this?
1: CE announcement is immanent!
2: Confident that we have ticked all the boxes for approval!
3: Expecting a decent SP rise!
4: When we have our devices, sky is the limit!
Furthermore, being that CE is expected this may shed some light on any delays (as mentioned in the above notification): "Notified bodies have been experiencing a surge in workload for a combination of reasons, including revision to guidelines of regulatory standard ISO13485:2016, for which all companies are required to comply with by 2019."
What an exciting world we live in, all IMO, enjoy your day!
Dave
(20min delay)